Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 210

1.

Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.

Anyaegbu EI, Shaw AS, Hruska KA, Jain S.

Pediatr Nephrol. 2015 Jun;30(6):983-9. doi: 10.1007/s00467-014-3031-0. Epub 2014 Dec 23.

PMID:
25530085
2.

Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease.

Seifert ME, de Las Fuentes L, Ginsberg C, Rothstein M, Dietzen DJ, Cheng SC, Ross W, Windus D, Dávila-Román VG, Hruska KA.

Am J Nephrol. 2014;39(5):392-9. doi: 10.1159/000362251. Epub 2014 May 6.

3.

CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder.

Fang Y, Ginsberg C, Seifert M, Agapova O, Sugatani T, Register TC, Freedman BI, Monier-Faugere MC, Malluche H, Hruska KA.

J Am Soc Nephrol. 2014 Aug;25(8):1760-73. doi: 10.1681/ASN.2013080818. Epub 2014 Feb 27.

PMID:
24578135
4.

Expression of DGCR8-dependent microRNAs is indispensable for osteoclastic development and bone-resorbing activity.

Sugatani T, Hildreth BE 3rd, Toribio RE, Malluche HH, Hruska KA.

J Cell Biochem. 2014 Jun;115(6):1043-7. doi: 10.1002/jcb.24759.

PMID:
24420069
5.

Sclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study.

Register TC, Hruska KA, Divers J, Bowden DW, Palmer ND, Carr JJ, Wagenknecht LE, Hightower RC, Xu J, Smith SC, Dietzen DJ, Langefeld CD, Freedman BI.

J Clin Endocrinol Metab. 2014 Jan;99(1):315-21. doi: 10.1210/jc.2013-3168. Epub 2013 Dec 20.

6.

Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease.

Seifert ME, de las Fuentes L, Rothstein M, Dietzen DJ, Bierhals AJ, Cheng SC, Ross W, Windus D, Dávila-Román VG, Hruska KA.

Am J Nephrol. 2013;38(2):158-67. doi: 10.1159/000353569. Epub 2013 Aug 7.

7.

Early chronic kidney disease-mineral bone disorder stimulates vascular calcification.

Fang Y, Ginsberg C, Sugatani T, Monier-Faugere MC, Malluche H, Hruska KA.

Kidney Int. 2014 Jan;85(1):142-50. doi: 10.1038/ki.2013.271. Epub 2013 Jul 24.

8.

HDAC dependent transcriptional repression of Bmp-7 potentiates TGF-β mediated renal fibrosis in obstructive uropathy.

Manson SR, Song JB, Hruska KA, Austin PF.

J Urol. 2014 Jan;191(1):242-52. doi: 10.1016/j.juro.2013.06.110. Epub 2013 Jun 29.

9.

Relationships between serum adiponectin and bone density, adiposity and calcified atherosclerotic plaque in the African American-Diabetes Heart Study.

Register TC, Divers J, Bowden DW, Carr JJ, Lenchik L, Wagenknecht LE, Hightower RC, Xu J, Smith SC, Hruska KA, Langefeld CD, Freedman BI.

J Clin Endocrinol Metab. 2013 May;98(5):1916-22. doi: 10.1210/jc.2012-4126. Epub 2013 Mar 29.

10.

Down-regulation of miR-21 biogenesis by estrogen action contributes to osteoclastic apoptosis.

Sugatani T, Hruska KA.

J Cell Biochem. 2013 Jun;114(6):1217-22. doi: 10.1002/jcb.24471.

11.

Admixture mapping of coronary artery calcified plaque in African Americans with type 2 diabetes mellitus.

Divers J, Palmer ND, Lu L, Register TC, Carr JJ, Hicks PJ, Hightower RC, Smith SC, Xu J, Cox AJ, Hruska KA, Bowden DW, Lewis CE, Heiss G, Province MA, Borecki IB, Kerr KF, Chen YD, Palmas W, Rotter JI, Wassel CL, Bertoni AG, Herrington DM, Wagenknecht LE, Langefeld CD, Freedman BI.

Circ Cardiovasc Genet. 2013 Feb;6(1):97-105. doi: 10.1161/CIRCGENETICS.112.964114. Epub 2012 Dec 11.

12.

Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study.

Murea M, Register TC, Divers J, Bowden DW, Carr JJ, Hightower CR, Xu J, Smith SC, Hruska KA, Langefeld CD, Freedman BI.

BMC Nephrol. 2012 Nov 14;13:148. doi: 10.1186/1471-2369-13-148.

13.

Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes.

Register TC, Hruska KA, Divers J, Bowden DW, Palmer ND, Carr JJ, Wagenknecht LE, Hightower RC, Xu J, Smith SC, Dietzen DJ, Langefeld CD, Freedman BI.

J Clin Endocrinol Metab. 2013 Jan;98(1):E60-5. doi: 10.1210/jc.2012-3038. Epub 2012 Nov 2.

14.

Endogenous BMP-7 is a critical molecular determinant of the reversibility of obstruction-induced renal injuries.

Manson SR, Niederhoff RA, Hruska KA, Austin PF.

Am J Physiol Renal Physiol. 2011 Dec;301(6):F1293-302. doi: 10.1152/ajprenal.00071.2011. Epub 2011 Aug 31.

15.

The BMP-7-Smad1/5/8 pathway promotes kidney repair after obstruction induced renal injury.

Manson SR, Niederhoff RA, Hruska KA, Austin PF.

J Urol. 2011 Jun;185(6 Suppl):2523-30. doi: 10.1016/j.juro.2011.01.034. Epub 2011 Apr 27.

16.

Relationships between calcified atherosclerotic plaque and bone mineral density in African Americans with type 2 diabetes.

Divers J, Register TC, Langefeld CD, Wagenknecht LE, Bowden DW, Carr JJ, Hightower RC, Xu J, Hruska KA, Freedman BI.

J Bone Miner Res. 2011 Jul;26(7):1554-60. doi: 10.1002/jbmr.389.

17.

RGS4, a GTPase activator, improves renal function in ischemia-reperfusion injury.

Siedlecki AM, Jin X, Thomas W, Hruska KA, Muslin AJ.

Kidney Int. 2011 Aug;80(3):263-71. doi: 10.1038/ki.2011.63. Epub 2011 Mar 16.

18.

The roles of the skeleton and phosphorus in the CKD mineral bone disorder.

Hruska KA, Mathew S.

Adv Chronic Kidney Dis. 2011 Mar;18(2):98-104. doi: 10.1053/j.ackd.2011.01.001.

19.

A microRNA expression signature of osteoclastogenesis.

Sugatani T, Vacher J, Hruska KA.

Blood. 2011 Mar 31;117(13):3648-57. doi: 10.1182/blood-2010-10-311415. Epub 2011 Jan 27.

20.

Genomic signatures predict migration and spawning failure in wild Canadian salmon.

Miller KM, Li S, Kaukinen KH, Ginther N, Hammill E, Curtis JM, Patterson DA, Sierocinski T, Donnison L, Pavlidis P, Hinch SG, Hruska KA, Cooke SJ, English KK, Farrell AP.

Science. 2011 Jan 14;331(6014):214-7. doi: 10.1126/science.1196901.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk